Skip to main content
UniHealth

Doctor search

Fatima Rodriguez, MD

Cardiovascular Disease (Cardiology) · Stanford

NPI 1184918393

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
20
4 carriers
Offices
6

Offices

6 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

20 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rodriguez’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

20 of 20 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A129900 · Current

Licensed to practise in California · since 2014 · expires 2027-08-31 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$26,927

Medicare paid this office $26,927 for 738 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Initial hospital care with moderate level of medical decision making at least 75 minutes37$5,873$155
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only573$4,448$7
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$4,120$106
Return visit (30+ min)17$2,188$115
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,280$116
See all 9 services
Every Original Medicare service billed
Initial hospital care with moderate level of medical decision making at least 75 minutes37$5,873$155
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only573$4,448$7
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$4,120$106
Return visit (30+ min)17$2,188$115
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,280$116
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$1,265$70
Hospital discharge day management, 30 minutes or less13$886$68
Heart rhythm review and interpretation of continous external ekg over 8-15 days43$799$18
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report19$224$12

Who their Medicare patients are

738 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 17% · Women 50% · Also on Medicaid 28% · Health risk score 2.34. Above the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Atrial fibrillation 46% · Chronic kidney disease 44% · Diabetes 41% · Heart failure 41% · Depression 26% · Cancer 23% · COPD 20% · Dementia 19% · Stroke 18%.

The office billed $153,173, Medicare allowed $35,382 and paid $26,927; for 917 services of 19 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024738917752.34$153,173$26,927
2023563761742.31$155,594$30,887
2022425581752.34$151,054$31,745
2021453549742.44$78,915$12,021
2020243398722.70$110,403$22,188
2019233355752.43$81,892$20,082
2018239332732.09$78,461$19,772
201763116771.85$37,357$10,358

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes31$7,112$109
Initial hospital care with moderate level of medical decision making at least 75 minutes45$7,038$156
Long return visit (40+ min)23$3,694$115
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only416$3,441$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes23$2,408$73
Hospital discharge day management, 30 minutes or less26$1,974$76
Return visit (30+ min)17$1,356$75
Heart rhythm review and interpretation of continous external ekg over 8-15 days27$646$24

2022: 10 services

Original Medicare services billed in 2022
Initial hospital care with moderate level of medical decision making at least 75 minutes29$5,292$182
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes36$5,250$94
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes33$4,060$123
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes34$3,127$65
Long return visit (40+ min)17$2,656$121
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only255$2,013$7
Hospital discharge day management, 30 minutes or less29$1,945$67
Return visit (30+ min)15$1,540$91
Hospital observation care on day of discharge11$785$71
Heart rhythm review and interpretation of continous external ekg over 8-15 days19$475$25

2021: 4 services

Original Medicare services billed in 2021
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only379$3,208$7
Long return visit (40+ min)14$2,360$124
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$2,130$125
Heart rhythm review and interpretation of continous external ekg over 8-15 days27$636$24

2020: 8 services

Original Medicare services billed in 2020
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes30$3,945$127
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$3,093$67
Initial hospital care with moderate level of medical decision making at least 75 minutes16$3,074$192
Return visit (30+ min)20$1,987$71
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$1,948$97
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only135$1,284$8
Hospital discharge day management, 30 minutes or less14$974$70
Review and interpretation of external ekg recording for more than 48 hours up to 21 days22$610$23

2019: 5 services

Original Medicare services billed in 2019
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes33$4,024$122
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$3,057$65
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes13$2,138$93
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only141$1,186$8
Hospital discharge day management, 30 minutes or less16$1,065$67

2018: 5 services

Original Medicare services billed in 2018
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes46$5,744$122
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes25$2,746$65
Long return visit (40+ min)14$1,901$95
Long return visit (40+ min)11$1,097$91
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only130$1,040$8

2017: 3 services

Original Medicare services billed in 2017
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes27$3,417$122
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes23$2,332$65
Hospital discharge day management, 30 minutes or less11$795$66

Medicaid work

$5,827 in 2024

Medicaid paid $5,827 for 492 billed services this clinician did in 2024, up to 118 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only492$5,827
Medicaid work by year
20244921118$5,827
20234071114$4,370
2022223189$2,673
20214081154$4,405
2020119149$1,519
2019102192$1,201
201883148$947
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only407$4,370

2022

Largest Medicaid services in 2022
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only223$2,673

2021

Largest Medicaid services in 2021
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only408$4,405

2020

Largest Medicaid services in 2020
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only119$1,519

2019

Largest Medicaid services in 2019
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only102$1,201

2018

Largest Medicaid services in 2018
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only83$947

Drugs they prescribed that Part D paid

$55,316

Pharmacies billed $55,316 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 416) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

371 generic and 45 brand-name prescriptions · $55,316 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Vascepa12$4,285$357
Dabigatran Etexilate12$2,015$168
Rosuvastatin54$964$18
Ezetimibe30$891$30
Metoprolol48$641$13
See all 9 drugs
Every Part D drug this clinician prescribed
Vascepa12$4,285$357
Dabigatran Etexilate12$2,015$168
Rosuvastatin54$964$18
Ezetimibe30$891$30
Metoprolol48$641$13
Losartan55$445$8
Amlodipine Besylate40$299$7
Clopidogrel14$293$21
Atorvastatin30$285$10

Year by year

Part D prescribing by year
2024416640% (0)11%$55,316
2023357510% (0)21%$81,402
2022374580% (0)15%$57,339
2021247290% (0)13%$28,039
2020326430% (0)10%$27,295
2019190380% (0)18%$22,696
2018134330% (0)9%$11,201
201764220% (0)None$7,303
201567210% (0)30%$5,736
201455240NoneNone$39,451
201366147None23%$43,844

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 11 drugs

Part D drugs prescribed in 2023
Eliquis29$31,265$1,078
Praluent14$9,960$711
Vascepa12$4,556$380
Icosapent Ethyl11$2,860$260
Rosuvastatin45$1,155$26
Metoprolol35$769$22
Clopidogrel12$381$32
Amlodipine Besylate32$370$12
Ezetimibe16$354$22
Losartan34$244$7
Atorvastatin18$243$14

2022: 11 drugs

Part D drugs prescribed in 2022
Xarelto11$12,226$1,111
Praluent15$8,628$575
Vascepa12$4,610$384
Rosuvastatin55$1,359$25
Ezetimibe24$896$37
Metoprolol40$736$18
Losartan37$380$10
Carvedilol18$286$16
Atorvastatin22$249$11
Amlodipine Besylate35$223$6
Hydrochlorothiazide11$30$3

2021: 6 drugs

Part D drugs prescribed in 2021
Ezetimibe22$1,455$66
Rosuvastatin27$622$23
Metoprolol28$565$20
Losartan27$555$21
Atorvastatin20$247$12
Amlodipine Besylate30$131$4

2020: 9 drugs

Part D drugs prescribed in 2020
Eliquis13$11,299$869
Ezetimibe29$1,087$37
Metoprolol41$894$22
Rosuvastatin26$766$29
Atorvastatin35$533$15
Losartan28$436$16
Diltiazem 24hr Er (Cd)14$320$23
Clopidogrel16$237$15
Amlodipine Besylate34$211$6

2019: 5 drugs

Part D drugs prescribed in 2019
Eliquis19$11,991$631
Metoprolol36$942$26
Atorvastatin29$540$19
Rosuvastatin11$357$32
Amlodipine Besylate12$63$5

2018: 4 drugs

Part D drugs prescribed in 2018
Atorvastatin32$359$11
Metoprolol16$254$16
Amlodipine Besylate14$39$3
Lisinopril13$21$2

2017: 1 drug

Part D drugs prescribed in 2017
Metoprolol12$184$15

2014: 16 drugs

Part D drugs prescribed in 2014
Lantus Solostar17$5,509$324
Spiriva18$5,223$290
Lantus12$2,848$237
Omeprazole53$1,025$19
Proair Hfa14$975$70
Metoprolol22$787$36
Fluticasone Propionate19$608$32
Polyethylene Glycol 335012$370$31
Lisinopril37$349$9
Atorvastatin13$234$18
Metformin22$225$10
Simvastatin28$202$7
Amlodipine Besylate21$169$8
Hydrochlorothiazide33$135$4
Furosemide14$56$4
Trazodone11$36$3

2013: 18 drugs

Part D drugs prescribed in 2013
Lantus21$6,215$296
Spiriva20$5,498$275
Lantus Solostar14$2,765$198
Metoprolol28$1,235$44
Gabapentin18$1,000$56
Proair Hfa14$977$70
Omeprazole38$739$19
Fluticasone Propionate20$548$27
Polyethylene Glycol 335015$445$30
Simvastatin37$421$11
Lisinopril34$354$10
Atorvastatin13$294$23
Metformin32$289$9
Amlodipine Besylate19$194$10
Metformin Hcl Er14$176$13
Hydrochlorothiazide24$86$4
Citalopram Hbr12$84$7
Furosemide13$61$5

Money from drug and device companies

$71,982 in 2025

Industry payments by year
2025538$70,794$71,982
2024736$35,737$40,112
2023316$3,688$4,368
202226None$366
202123$3,570$3,673
2020313$16,620$18,187
201912None$57

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Novartis PharmaceuticalsLeqvio$28,248
14 payments
  • Consulting for Leqvio · 2025-12-22 · $1,800
  • Consulting for Leqvio · 2025-12-08 · $2,700
  • Meals · 2025-11-11 · $11
  • Meals · 2025-11-10 · $10
  • Consulting for Leqvio · 2025-11-10 · $900
  • Meals for Leqvio · 2025-11-08 · $137
  • Consulting for Leqvio · 2025-10-03 · $3,600
  • Meals for Leqvio · 2025-08-29 · $147
  • Consulting for Leqvio · 2025-06-18 · $2,700
  • Consulting for Leqvio · 2025-05-06 · $3,600
  • Meals for Leqvio · 2025-02-04 · $44
  • Consulting · 2025-01-21 · $4,500
  • Consulting · 2025-01-17 · $4,500
  • Consulting for Leqvio · 2025-01-01 · $3,600
HeartflowFfrct$23,831
11 payments
  • Consulting for Ffrct · 2025-12-19 · $400
  • Paid to speak or teach for Ffrct · 2025-12-19 · $4,000
  • Consulting for Ffrct · 2025-12-19 · $2,000
  • Meals for Ffrct · 2025-11-09 · $31
  • Consulting for Ffrct · 2025-09-18 · $400
  • Consulting for Ffrct · 2025-09-18 · $800
  • Consulting for Ffrct · 2025-09-18 · $2,400
  • Consulting for Ffrct · 2025-06-30 · $10,000
  • Consulting for Ffrct · 2025-06-05 · $1,600
  • Consulting for Ffrct · 2025-06-05 · $400
  • Consulting for Ffrct · 2025-03-07 · $1,800
Edwards LifesciencesEdwards Sapien 3 Transcatheter Heart Valve (Thv)$11,544
7 payments
  • Meals for Sapien 3 Ultra Resilia · 2025-12-13 · $232
  • Meals for Sapien 3 Ultra Resilia · 2025-12-13 · $116
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2025-12-09 · $1,875
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2025-10-01 · $2,344
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2025-05-29 · $5,000
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2025-05-22 · $1,875
  • Meals · 2025-03-29 · $103
Esperion TherapeuticsNexlizet$8,015
3 payments
  • Consulting for Nexlizet · 2025-11-13 · $4,800
  • Meals for Nexletol · 2025-11-09 · $15
  • Consulting for Nexlizet · 2025-07-08 · $3,200
CleerlyCleerly Ischemia$343
3 payments
  • Meals for Cleerly Ischemia · 2025-08-29 · $142
  • Meals for Cleerly Ischemia · 2025-08-02 · $71
  • Meals for Cleerly Ischemia · 2025-08-01 · $130
See all 38 published payments
Every published payment
Novartis PharmaceuticalsConsulting · 2025-12-22Leqvio$1,800
HeartflowConsulting · 2025-12-19Ffrct$400
HeartflowPaid to speak or teach · 2025-12-19Ffrct$4,000
HeartflowConsulting · 2025-12-19Ffrct$2,000
Edwards LifesciencesMeals · 2025-12-13Sapien 3 Ultra Resilia$232
Edwards LifesciencesMeals · 2025-12-13Sapien 3 Ultra Resilia$116
Edwards LifesciencesConsulting · 2025-12-09Edwards Sapien 3 Transcatheter Heart Valve (Thv)$1,875
Novartis PharmaceuticalsConsulting · 2025-12-08Leqvio$2,700
Esperion TherapeuticsConsulting · 2025-11-13Nexlizet$4,800
Novartis PharmaceuticalsMeals · 2025-11-11None$11
Novartis PharmaceuticalsMeals · 2025-11-10None$10
Novartis PharmaceuticalsConsulting · 2025-11-10Leqvio$900
HeartflowMeals · 2025-11-09Ffrct$31
Esperion TherapeuticsMeals · 2025-11-09Nexletol$15
Novartis PharmaceuticalsMeals · 2025-11-08Leqvio$137
Novartis PharmaceuticalsConsulting · 2025-10-03Leqvio$3,600
Edwards LifesciencesConsulting · 2025-10-01Edwards Sapien 3 Transcatheter Heart Valve (Thv)$2,344
HeartflowConsulting · 2025-09-18Ffrct$400
HeartflowConsulting · 2025-09-18Ffrct$800
HeartflowConsulting · 2025-09-18Ffrct$2,400
Novartis PharmaceuticalsMeals · 2025-08-29Leqvio$147
CleerlyMeals · 2025-08-29Cleerly Ischemia$142
CleerlyMeals · 2025-08-02Cleerly Ischemia$71
CleerlyMeals · 2025-08-01Cleerly Ischemia$130
Esperion TherapeuticsConsulting · 2025-07-08Nexlizet$3,200
HeartflowConsulting · 2025-06-30Ffrct$10,000
Novartis PharmaceuticalsConsulting · 2025-06-18Leqvio$2,700
HeartflowConsulting · 2025-06-05Ffrct$1,600
HeartflowConsulting · 2025-06-05Ffrct$400
Edwards LifesciencesConsulting · 2025-05-29Edwards Sapien 3 Transcatheter Heart Valve (Thv)$5,000
Edwards LifesciencesConsulting · 2025-05-22Edwards Sapien 3 Transcatheter Heart Valve (Thv)$1,875
Novartis PharmaceuticalsConsulting · 2025-05-06Leqvio$3,600
Edwards LifesciencesMeals · 2025-03-29None$103
HeartflowConsulting · 2025-03-07Ffrct$1,800
Novartis PharmaceuticalsMeals · 2025-02-04Leqvio$44
Novartis PharmaceuticalsConsulting · 2025-01-21None$4,500
Novartis PharmaceuticalsConsulting · 2025-01-17None$4,500
Novartis PharmaceuticalsConsulting · 2025-01-01Leqvio$3,600
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $40,112

Payments by company in 2024
Novartis PharmaceuticalsLeqvio$15,150
9 payments
  • Consulting · 2024-12-02 · $6,300
  • Meals for Leqvio · 2024-10-30 · $108
  • Travel · 2024-09-22 · $499
  • Meals · 2024-09-22 · $111
  • Meals · 2024-09-21 · $173
  • Consulting for Leqvio · 2024-04-06 · $2,975
  • Consulting for Leqvio · 2024-04-05 · $4,200
  • Meals for Leqvio · 2024-04-05 · $175
  • Travel for Leqvio · 2024-04-05 · $610
HeartflowFfrct$14,609
8 payments
  • Consulting for Ffrct · 2024-12-06 · $2,800
  • Consulting for Ffrct · 2024-12-06 · $2,400
  • Consulting for Ffrct · 2024-10-15 · $1,200
  • Consulting for Ffrct · 2024-08-30 · $2,400
  • Meals for Ffrct · 2024-08-05 · $109
  • Meals for Ffrct · 2024-07-25 · $100
  • Consulting for Ffrct · 2024-07-09 · $2,400
  • Consulting for Ffrct · 2024-04-23 · $3,200
AmgenNone$6,211
9 payments
  • Consulting · 2024-08-06 · $4,524
  • Travel · 2024-07-16 · $168
  • Meals · 2024-07-16 · $48
  • Meals · 2024-06-14 · $150
  • Travel · 2024-06-14 · $200
  • Meals · 2024-06-14 · $29
  • Meals · 2024-06-14 · $51
  • Meals · 2024-06-14 · $60
  • Travel · 2024-06-14 · $981
iRhythm TechnologiesZio Xt Patch$2,518
2 payments
  • Meals for Zio Monitor · 2024-11-15 · $118
  • Consulting for Zio Xt Patch · 2024-05-29 · $2,400
Edwards LifesciencesEdwards Sapien 3 Transcatheter Heart Valve (Thv)$1,355
3 payments
  • Meals for Sapien 3 Ultra Resilia · 2024-12-08 · $233
  • Meals · 2024-11-16 · $185
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2024-01-04 · $938
Esperion TherapeuticsNexletol$207
3 payments
  • Meals for Nexletol · 2024-08-02 · $85
  • Meals for Nexletol · 2024-04-06 · $92
  • Meals for Nexletol · 2024-04-05 · $30
Novo NordiskWegovy$63
2 payments
  • Meals · 2024-12-10 · $48
  • Meals for Wegovy · 2024-11-18 · $15

2023: $4,368

Payments by company in 2023
Edwards LifesciencesEdwards Sapien 3 Transcatheter Heart Valve (Thv)$2,341
2 payments
  • Consulting for Edwards Sapien 3 Transcatheter Heart Valve (Thv) · 2023-12-21 · $2,188
  • Meals · 2023-11-11 · $153
Novartis PharmaceuticalsLeqvio$1,992
13 payments
  • Meals for Leqvio · 2023-12-09 · $17
  • Meals for Leqvio · 2023-12-09 · $12
  • Meals for Leqvio · 2023-12-08 · $10
  • Meals for Leqvio · 2023-12-08 · $75
  • Meals for Leqvio · 2023-11-11 · $18
  • Meals for Leqvio · 2023-08-19 · $33
  • Meals for Leqvio · 2023-08-18 · $130
  • Meals for Leqvio · 2023-08-18 · $89
  • Meals · 2023-05-15 · $15
  • Meals · 2023-04-27 · $13
  • Meals for Leqvio · 2023-03-05 · $66
  • Meals · 2023-02-08 · $13
  • Consulting for Leqvio · 2023-01-24 · $1,500
Esperion TherapeuticsNexletol$36
1 payment
  • Meals for Nexletol · 2023-11-11 · $36

2022: $366

Payments by company in 2022
Novartis PharmaceuticalsLeqvio$255
5 payments
  • Meals for Leqvio · 2022-11-07 · $16
  • Meals for Entresto · 2022-11-06 · $18
  • Meals for Leqvio · 2022-11-05 · $27
  • Meals for Leqvio · 2022-04-02 · $117
  • Meals for Kesimpta · 2022-03-17 · $76
Janssen Scientific AffairsXarelto$112
1 payment
  • Meals for Xarelto · 2022-09-09 · $112

2021: $3,673

Payments by company in 2021
AmgenNone$3,570
2 payments
  • Consulting · 2021-11-05 · $2,380
  • Consulting · 2021-11-05 · $1,190
Novartis PharmaceuticalsEntresto$103
1 payment
  • Meals for Entresto · 2021-10-20 · $103

2020: $18,187

Payments by company in 2020
Janssen Global ServicesNone$14,557
11 payments
  • Consulting · 2020-02-19 · $13,020
  • Travel · 2020-02-19 · $91
  • Meals · 2020-02-19 · $113
  • Travel · 2020-01-28 · $446
  • Travel · 2020-01-28 · $608
  • Travel · 2020-01-28 · $51
  • Meals · 2020-01-28 · $50
  • Meals · 2020-01-28 · $114
  • Meals · 2020-01-28 · $15
  • Meals · 2020-01-28 · $15
  • Meals · 2020-01-28 · $35
E.R. Squibb & Sons L.L.C.None$3,600
1 payment
  • Consulting · 2020-11-30 · $3,600
Janssen PharmaceuticalsXarelto$30
1 payment
  • Meals for Xarelto · 2020-02-11 · $30

2019: $57

Payments by company in 2019
Janssen Scientific AffairsXarelto$57
2 payments
  • Meals for Xarelto · 2019-08-28 · $12
  • Meals for Xarelto · 2019-03-26 · $45

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novo Nordisk AS · Wegovy · 2022This clinician$59,800
Novo Nordisk AS · Wegovy · 2023This clinician$35,750
Novo Nordisk AS · 2020Their institution$30,300
Novo Nordisk AS · Wegovy · 2021Their institution$26,525
Novo Nordisk AS · Rybelsus · 2022This clinician$25,850
Novo Nordisk AS · Rybelsus · 2023This clinician$24,425
Cleerly, Inc. · Transform · 2025This clinician$18,587
Novo Nordisk AS · Rybelsus · 2024This clinician$17,225
Novo Nordisk AS · Rybelsus · 2021Their institution$13,475
NOVARTIS PHARMACEUTICALS CORPORATION · Publication Support Provided in Connection With Heor Research · 2022This clinician$10,964
Novartis Pharmaceuticals Corporation · Ckjx839a1us02 · 2024This clinician$9,012
Novo Nordisk AS · 2019Their institution$8,300
Novo Nordisk AS · Rybelsus · 2020Their institution$7,475
Novo Nordisk AS · Ozempic · 2022This clinician$5,475
Novartis Pharmaceuticals Corporation · Research Publication/ Writing Support · 2025This clinician$4,337
Novo Nordisk AS · Ozempic · 2021Their institution$3,300
Novo Nordisk AS · Ozempic · 2020Their institution$3,300
Cleerly, Inc. · Cleerly Web Series · 2025This clinician$3,000
Novo Nordisk AS · Ozempic · 2023This clinician$2,925
Regeneron Pharmaceuticals, Inc. · Praluent Clinical Development Program · 2024This clinician$2,499
Novo Nordisk AS · Rybelsus · 2021This clinician$1,975
Amgen Inc. · A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing Olpasiran Use To Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(A) · 2025This clinician$1,716
Novartis Pharmaceuticals Corporation · Research Publication/Writing Support · 2025This clinician$1,307
Cleerly, Inc. · Confirm2 · 2025This clinician$1,200
Novo Nordisk AS · Ozempic · 2024This clinician$700
Novartis Pharmaceuticals Corporation · A Randomized, Multicenter, Open-Label Trial Comparing the Effectiveness of An """"Inclisiran First"""" Implementation Strategy To Usual Care on Ldl Cholesterol (Ldl-C) in Patients With Atherosclerotic Cardiovascular Disease and Elevated Ldl-C (?70 Mg/Dl) Despite Receiving Maximally Tolerated Statin Therapy (Victorion-Initiate)""" · 2021This clinician$407

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1184918393
Licence
CA A129900California A129900: Current · expires 2027-08-31
Trained
Harvard Medical School, 2011
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Cardiology (207RC0000X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2011-06-06
NPI last updated
2024-04-24
NPI record certified
2024-04-24

This is when the NPI record was last certified, not a medical board exam.